Search review questions

Severity of anxiety in patients HADS‐A (at hospital discharge or at 28 days, whichever time point was soonest); scale from 0 to 20 Lower scores indicate less anxiety. · adult ICU patients and their carers

Severity of depression in patients HADS‐D (at hospital discharge or 28 days, whichever time point was soonest); scale from 0 to 20 Lower scores indicate less depression. · adult ICU patients and their carers

Behavioural outcome: immunisation rate ATCS Plus, IVR, unidirectional versus no calls, letters, usual care at median · participants at risk of under‐immunisation (children, adolescents and adults)

Clinical outcome: body weight measures Multimodal/complex interventiond ATCS Plus versus usual care or control · participants at risk of developing long‐term conditions

Adverse outcome: unintended adverse events attributable to the intervention Multimodal/complex intervention, ATCS Plus, IVR versus various controls · participants at risk of developing long‐term conditions

Behavioural outcome: breast cancer screening Multimodal/complex intervention versus usual care at 12 months · participants at risk for breast, colorectal or cervical cancer; or osteoporosis

Behavioural outcome: breast cancer screening IVR versus enhanced usual care at median · participants at risk for breast, colorectal or cervical cancer; or osteoporosis

Behavioural outcome: colorectal cancer screening Multimodal/complex intervention versus usual care at median · participants at risk for breast, colorectal or cervical cancer; or osteoporosis

Behavioural outcome: colorectal cancer screening IVR versus usual care at 6‐month · participants at risk for breast, colorectal or cervical cancer; or osteoporosis

Behavioural outcome: colorectal cancer screening IVR, unidirectional ATCS versus usual care or letter at longer (9‐12 months) · participants at risk for breast, colorectal or cervical cancer; or osteoporosis

Behavioural outcome: cervical cancer screening ATCS Plus versus control (no calls) at 3 month · participants at risk for breast, colorectal or cervical cancer; or osteoporosis

Adverse outcome: unintended adverse events attributable to the intervention Multimodal/complex intervention, ATCS Plus, IVR, unidirectional versus various controls · participants at risk for breast, colorectal or cervical cancer; or osteoporosis

Clinical and behavioural outcome: BMI score in adults Multimodal/complex intervention, ATCS Plus or IVR versus usual care at median · overweight or obese individuals (both children and adults)

Behavioural outcome: immunisation rate Unidirectional ATCS versus usual care at median · participants at risk of under‐immunisation (children, adolescents and adults)

Clinical and behavioural outcome: body weight in adults, 12 weeks · overweight or obese individuals (both children and adults)

Clinical and behavioural outcome: body weight in adults, at median · overweight or obese individuals (both children and adults)

Clinical and behavioural outcome: blood pressure, blood glucose, cholesterol levels · overweight or obese individuals (both children and adults)

Clinical outcome: BMI z‐score in children at median · overweight or obese individuals (both children and adults)

Behavioural outcome: physical activity, dietary habits in children at median · overweight or obese individuals (both children and adults)

Adverse outcome: unintended adverse events attributable to the intervention IVR versus usual care · overweight or obese individuals (both children and adults)

Health behaviour: attendance rates, 6 weeks ATCS Plus versus nurse‐delivered calls · patients/healthcare consumers

Health behaviour: attendance rates, 4 months IVR versus no calls · patients/healthcare consumers

Health behaviour: return tuberculin test rate, 3 days Unidirectional ATCS versus no calls · patients/healthcare consumers

Health behaviour: attendance rates, 1 month Unidirectional ATCS versus no calls · patients/healthcare consumers

Behavioural outcome: immunisation rate Unidirectional ATCS versus no calls or health information at median · participants at risk of under‐immunisation (children, adolescents and adults)

Health behaviour: attendance rates, 6‐8 weeks Unidirectional ATCS versus no calls · patients/healthcare consumers

Health behaviour: attendance rates, 6 months Unidirectional ATCS versus no calls · patients/healthcare consumers

Adverse outcome: unintended adverse events attributable to the intervention ATCS Plus, IVR, unidirectional ATCS versus various controls · patients/healthcare consumers

Behavioural outcome: adherence to medication Multimodal/complex interventionsb versus usual care or control · patients with various conditions or at risk of low adherence to medication or laboratory tests

Behavioural outcome: adherence to medication ATCS Plus versus control or single IVR call · patients with various conditions or at risk of low adherence to medication or laboratory tests

Behavioural outcome: adherence to laboratory tests ATCS Plus or IVR versus no intervention or usual care · patients with various conditions or at risk of low adherence to medication or laboratory tests

Behavioural outcome: adherence to medication or composite outcome (medication adherence and rate of adverse events) ATCS Plus versus usual care · patients with various conditions or at risk of low adherence to medication or laboratory tests

Behavioural outcome: adherence to medication or laboratory tests IVR versus control · patients with various conditions or at risk of low adherence to medication or laboratory tests

Behavioural outcome: adherence to medication IVR versus usual care · patients with various conditions or at risk of low adherence to medication or laboratory tests

Behavioural outcome: adherence to medication Unidirectional ATCS versus control · patients with various conditions or at risk of low adherence to medication or laboratory tests

Adverse outcome: unintended adverse events attributable to the intervention ATCS+, IVR, unidirectional versus various controls · participants at risk of under‐immunisation (children, adolescents and adults)

Clinical outcome: blood pressure Multimodal/complex, ATCS Plus, IVR versus usual care · patients with various conditions or at risk of low adherence to medication or laboratory tests

Adverse outcome: unintended adverse events attributable to the intervention Multimodal/complex intervention, ATCS Plus, IVR, unidirectional versus various controls · patients with various conditions or at risk of low adherence to medication or laboratory tests

Behavioural outcomes: number of drinks per drinking day ATCS Plus, IVR versus usual care, (various) controls at median · participants addicted to alcohol

Behavioural outcomes: drinking days, heavy drinking days, or total number of drinks consumed ATCS Plus, IVR versus (various) controls · participants addicted to alcohol

Behavioural outcomes: proportion of days abstinent, other alcohol consumption indices, 12 weeks ATCS Plus versus control (packaged CBT) · participants addicted to alcohol

Behavioural outcomes: weekly alcohol consumption, 6 months ATCS Plus versus usual care · participants addicted to alcohol

Behavioural outcomes: AUDIT score, 6 weeks IVR versus control (no intervention) · participants addicted to alcohol

Behavioural outcomes: other alcohol consumption indices, 4 weeks IVR versus control (no intervention) · participants addicted to alcohol

Adverse outcome: unintended adverse events attributable to the intervention ATCS Plus, IVR versus various controls · participants addicted to alcohol

Clinical outcomes: symptoms (severity or burden) ATCS Plus versus usual care (via ATCS) or control, 4‐12 weeks · cancer patients

Behavioural outcome: physical activity Multimodal/complex interventionb versus no calls · participants at risk of developing long‐term conditions

Clinical outcomes: symptom severity, 10 weeks IVR versus nurse delivered calls · cancer patients

Clinical outcomes: pain Multimodal/complex interventiong versus usual care · cancer patients

Clinical outcomes: depression Multimodal/complex interventiong versus usual care · cancer patients